Garheng Kong, MD, PhD

Managing Partner - HealthQuest Capital

Garheng is the Founder and Managing Partner of Sofinnova HealthQuest, a healthcare focused investment firm, and has been a healthcare investor since 2000. He was a General Partner at Sofinnova Ventures and Intersouth Partners. Garheng has served as chairman and director on the boards of numerous companies, and operated as interim CEO for two venture-backed companies. Specifically, he served as the founding investor and Chairman of Cellective Therapeutics (acquired by AstraZeneca), Chairman of Serenex (acquired by Pfizer), Chairman of Novamin Technologies (acquired by GlaxoSmithKline), Chairman of Cempra Pharmaceuticals (Nasdaq: CEMP), and lead investor of the first financing for Alimera Sciences (Nasdaq: ALIM). Garheng has also led investments in Viamet Pharmaceuticals (Chairman), Proteon Therapeutics, Applied Genetic Technology Corporation, TransEnterix (OTCBB: TRXC), Calibra Medical (acquired by J&J), Athenix (acquired by Bayer, board observer), Aldagen (acquired by Cytomedix), Histogenics (Chairman), Salveo Specialty Pharmacy, SARcode Bioscience Inc. (acquired by Shire) and First Aid Beverages, Inc. Additionally he sits on the board of Laboratory Corporation of America (NYSE: LH) and the Duke University Medical Center Board of Visitors.

As an active leader in the healthcare community, Garheng serves or has served on the boards of directors of the SEBIO organization, the North Carolina Biotechnology Center, the Council for Entrepreneurial Development (CED), the Hamner Institutes for Life Sciences, the North Carolina Medical Device Organization, the University of Florida Biotechnology Council, the University of Virginia Ivy Foundation, the Pennsylvania Life Sciences Greenhouse, the Southeast Universities Research Association, the Investor Advisory Board for the Florida Institute for the Commercialization of Public Research, Corporate Chaplains of America and the Duke Medical Center Institutional Review Board (IRB).

Prior to his investing career, Garheng spent time at GlaxoSmithKline, McKinsey & Company, and TherOx. He received his M.D. (Medical Scientist Training Program), Ph.D. in Biomedical Engineering, and M.B.A. from Duke University (where he also served on the faculty), graduating at the top of both his medical and business school classes. He also holds B.S. degrees in Chemical Engineering and Biological Sciences from Stanford University. Garheng lives in Menlo Park, CA with his wife and is a nationally ranked volleyball player and a food enthusiast.

Assistant: Anna Le. Email: anna(at)

Previous Investments

  • Aldagen   Acquired - Cytomedix
  • Alimera Sciences  Public - (Nasdaq: ALIM)
  • Applied Genetic Technology Corporation  
  • Athenix  Acquired - Bayer
  • Calibra Medical   Acquired - Johnson & Johnson
  • Cempra   Public - (Nasdaq: CEMP)
  • nContact Surgical  
  • Novamin Technologies  Acquired - GlaxoSmithKline
  • Proteon Therapeutics  
  • Serenex  Acquired - Pfizer
  • TransEnterix  
  • Viamet Pharmaceuticals  


(650) 681-8424


Representative Investments